Drug Search Results
More Filters [+]

Simendan

Alternative Names: simendan
Latest Update: 2024-07-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PDE3 Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Turkey

Approved Indications: None

Known Adverse Events: None

Company: Shanghai Jiao Tong University School of Medicine
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Simendan

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR1900026531

N/A

Not yet recruiting

Unknown

2020-06-30

Recent News Events